J. E. Davis
Known title: EVP-Gen. Diagnostics/CEO ElectCIK: 0001599837
Associated companies
Transaction History
| DGX | ▼ Sell | Open Market | 10,000 | $2.4M | 9/1/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 10,000 | $1.9M | 6/1/2026 | View on chart |
| DGX | ▲ Buy | Grant | 51,652 | $10.6M | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 26,414 | $5.4M | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Open Market | 10,000 | $2.1M | 3/2/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,968 | $608K | 3/2/2026 | View on chart |
| DGX | ▲ Buy | Grant | 15,857 | $0 | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,396 | $503K | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 3,788 | $784K | 2/18/2026 | View on chart |
| DGX | ▲ Buy | Option Exercise | 55,093 | $5.3M | 11/25/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 9,342 | $1.8M | 11/25/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 4,747 | $916K | 11/25/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 41,004 | $7.9M | 11/25/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 7,143 | $1.3M | 11/5/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 2,366 | $398K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 1,411 | $238K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 704 | $119K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 7,249 | $1.2M | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 4,905 | $828K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 2,764 | $469K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 6,950 | $1.2M | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 2,493 | $423K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 750 | $126K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 584 | $99K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 267 | $45K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 1,493 | $251K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 902 | $152K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 453 | $77K | 4/2/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 5,900 | $995K | 4/2/2025 | View on chart |
| DGX | ▲ Buy | Grant | 61,917 | $10.8M | 3/4/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 31,656 | $5.5M | 3/4/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,662 | $289K | 3/3/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,966 | $509K | 2/26/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,936 | $498K | 2/19/2025 | View on chart |
| DGX | ▲ Buy | Grant | 18,149 | $0 | 2/12/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 3,216 | $406K | 2/28/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,804 | $228K | 2/28/2024 | View on chart |
| DGX | ▲ Buy | Grant | 13,390 | $1.7M | 2/23/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 6,525 | $816K | 2/23/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 762 | $95K | 2/21/2024 | View on chart |
| DGX | ▲ Buy | Grant | 22,251 | $0 | 2/14/2024 | View on chart |
| DGX | ▲ Buy | Grant | 15,204 | $2.2M | 3/6/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 8,036 | $1.2M | 3/6/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,292 | $182K | 3/1/2023 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,473 | $218K | 2/23/2023 | View on chart |
| DGX | ▲ Buy | Grant | 17,443 | $0 | 2/23/2023 | View on chart |
| DGX | ▲ Buy | Grant | 13,980 | $0 | 11/1/2022 | View on chart |
| DGX | ▲ Buy | Grant | 19,856 | $2.6M | 3/7/2022 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 10,330 | $1.3M | 3/7/2022 | View on chart |
| DGX | ▲ Buy | Grant | 9,787 | $0 | 2/24/2022 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,712 | $223K | 2/23/2022 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 724 | $94K | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus
Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus. Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.